諾和諾德 NVO 深 滬
等待開盤 03-26 09:30:00 美东时间
36.33
-0.560
-1.52%
華盛通- 最 高37.39
- 今 開37.15
- 成交量 1638.54万股
- 最 低 36.23
- 昨 收 36.89
- 總市值 1622.13亿
- 52周最高 81.0284
- 市盈率 靜 10.43
- 換手率 0.37%
- 52周最低 35.85
- 委 比 67.73%
- 總股本 44.65亿
- 歷史最高 146.557
- 量 比 0.78
- 振 幅 3.14%
- 歷史最低 9.5975
- 每 手 1
- 風險率 10.09%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
今天 01:35
Semafor Reported Senators Reach Deal On Capping Insulin Costs At $35
https://www.semafor.com/article/03/24/2026/senators-reach-deal-on-capping-insulin-costs-at-35
03-25 18:23
专利悬崖压顶！跨国药企集体瘦身，赛诺菲减员超 8000 人
（来源：抗体圈） 行业格局逆转：从普遍扩张到集体收缩 对比近年数据，制药行业用人策略出现根本性反转。2022 年，17 家大型药企中仅 3 家启动裁员；到...
03-24 15:34
UPDATE 2-Temasek-backed Manipal Health files for India IPO, to raise $852 million via fresh issue
UPDATE 2-Temasek-backed Manipal Health files for India IPO, to raise $852 million via fresh issue Rewrites throughout with details from filing BENGALURU, March 24 (Reuters) - India's Manipal Health Enterprises will raise $852.2 million in a fresh issue for its initial public offering, betting on ris
03-24 15:00
India's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply
India's drugmakers roll out low-cost copies for Novo Nordisk's semaglutide, slashing prices up to 70% as analysts weigh global market disruption risks.
03-23 21:00
Novo Nordisk initiates Phase 1 trial of Lexicon-licensed obesity candidate LX9851
Novo Nordisk initiates Phase 1 trial of Lexicon-licensed obesity candidate LX9851 Novo Nordisk initiated a Phase 1 clinical study of LX9851, an oral non-incretin drug candidate licensed from Lexicon for obesity and associated metabolic disorders. The trial is evaluating safety and tolerability, and
03-23 19:31
司美格鲁肽在华核心专利到期，千亿市场“混战”开启
有“减重神药”之称的司美格鲁肽在电商平台的降价在继续。3月23日，记者注意到，降糖版司美格鲁肽（规格为1.34mg/ml*3ml）在部分电商平台的售价已经跌破...
03-23 18:55
减重版司美格鲁肽“上新”，更高剂量Wegovy已在美国获批，诺和诺德加速抢占肥胖症治疗高地
诺和诺德近日宣布，美国食品药品监督管理局（FDA）已批准Wegovy HD（每周一次司美格鲁肽注射液7.2 mg），用于降低过多体重并长期维持减重效果。FDA此...
03-23 15:53
